The COVID-19 pandemic has stretched healthcare resources and caused severe knock-on effects on patients with metabolic diseases worldwide. We encourage clinicians and patient-interest groups in the field of diabetes and metabolism to raise their voices to ensure adequate care and admission of patients.
Bornstein, S. R., Rubino, F., Ludwig, B., Rietzsch, H., Schwarz, P. E. H., Rodionov, R. N., Khunti, K., Hopkins, D., Birkenfeld, A. L., Boehm, B., Amiel, S., Holt, R. I. G., Skyler, J. S., Devries, J. H., Renard, E., Eckel, R. H., Zimmet, P., Alberti, K. G., Geloneze, B., Chan, J. C., Mbanya, J. C., Onyegbutulem, H. C., Ramachandran, A., Basit, A., Hassanein, M., Spinas, G. A., Beuschlein, F., Mingrone, G., Consequences of the COVID-19 pandemic for patients with metabolic diseases, <<NATURE METABOLISM>>, 2021; 3 (3): 289-292. [doi:10.1038/s42255-021-00358-y] [http://hdl.handle.net/10807/203306]
Consequences of the COVID-19 pandemic for patients with metabolic diseases
Mingrone, GeltrudeUltimo
2021
Abstract
The COVID-19 pandemic has stretched healthcare resources and caused severe knock-on effects on patients with metabolic diseases worldwide. We encourage clinicians and patient-interest groups in the field of diabetes and metabolism to raise their voices to ensure adequate care and admission of patients.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
